Cellular mechanism of the nonmonotonic dose response of bisphenol A in rat cardiac myocytes

Environmental Health Perspectives

Volumn 122, Issue 6, 2014, Pages 601-608

  Liang, Qian ^a,b   Gao, Xiaoqian ^b   Chen, Yamei ^b   Hong, Kui ^a   Wang, Hong Sheng ^b  

^a NANCHANG UNIVERSITY   (China)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4, 4' ISOPROPYLIDENEDIPHENOL; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; ESTROGEN RECEPTOR BETA; NIFEDIPINE; SERINE; THREONINE; UNCLASSIFIED DRUG; 4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; ENDOCRINE DISRUPTOR; PHENOL DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; FEMALE; FLUORESCENCE IMAGING; HEART ARRHYTHMIA; HEART MUSCLE CELL; IMAGING AND DISPLAY; NONHUMAN; NONMONOTONIC DOSE RESPONSE; PATCH CLAMP TECHNIQUE; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; VIDEO EDGE DETECTION; WESTERN BLOTTING; ANIMAL; CALCIUM SIGNALING; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; TOXICITY;

ANIMALS; ARRHYTHMIAS, CARDIAC; BENZHYDRYL COMPOUNDS; CALCIUM SIGNALING; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ESTROGEN RECEPTOR BETA; FEMALE; MYOCYTES, CARDIAC; PHENOLS; RATS; SARCOPLASMIC RETICULUM;

EID: 84901751481     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307491     Document Type: Article

References (30)

1. Belcher S.M., Chen Y, Yan S, Wang HS. 2012. Rapid estrogen receptor-mediated mechanisms determine the sexually dimorphic sensitivity of ventricular myocytes to 17β-estradiol and the environmental endocrine disruptor bisphenol A. Endocrinology 153:712-720.
2. Berger F., Borchard U, Hafner D, Pütz I, Weis TM. 1997. Effects of 17β-estradiol on action potentials and ionic currents in male rat ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 356:788-796.
3. Bers DM. 2002. Cardiac excitation-contraction coupling. Nature 415:198-205.
4. Cheng H., Lederer WJ, Cannell MB. 1993. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 262:740-744.
5. Conolly R.B., Lutz WK. 2004. Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment. Toxicol Sci 77:151-157.
6. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins G.S., Soto AM, et al. 2009. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30:293-342.
7. Eisner D., Bode E, Venetucci L, Trafford A. 2013. Calcium flux balance in the heart. J Mol Cell Cardiol 58:110-117.
8. Fagin D. 2012. Toxicology: the learning curve. Nature 490:462-465.
9. Gao X., Liang Q, Chen Y, Wang HS. 2013. Molecular mechanisms underlying the rapid arrhythmogenic action of bisphenol A in female rat hearts. Endocrinology 154:4607-4617.
10. Geens T., Aerts D, Berthot C, Bourguignon JP, Goeyens L, Lecomte P., et al. 2012. A review of dietary and non-dietary exposure to bisphenol-A. Food Chem Toxicol 50:3725-3740.
11. Jenkins S., Wang J, Eltoum I, Desmond R, Lamartiniere CA. 2011. Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. Environ Health Perspect 119:1604-160; doi:10.1289/ehp.1103850.
12. Kranias E.G., Hajjar RJ. 2012. Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ Res 110:1646-1660.
13. Kr channels and drug-induced prolongation of cardiac repolarization. J Physiol 586:2961-2973.
14. Lang I.A., Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace R.B., et al. 2008. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303-1310.
15. Melzer D., Osborne NJ, Henley WE, Cipelli R, Young A, Money C., et al. 2012. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 125:1482-1490.
16. Melzer D., Rice NE, Lewis C, Henley WE, Galloway TS. 2010. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLoS One 5:e8673; doi:10.1371/journal.pone.0008673.
17. Meyer R., Linz KW, Surges R, Meinardus S, Vees J, Hoffmann A, et al. 1998. Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat. Exp Physiol 83:305-321.
18. Myers J.P., Zoeller RT, vom Saal FS. 2009. A clash of old and new scientific concepts in toxicity, with important implications for public health. Environ Health Perspect 117:1652-165; doi:10.1289/ehp.0900887.
19. Nakajima T., Iwasawa K, Oonuma H, Morita T, Goto A, Wang Y, et al. 1999. Antiarrhythmic effect and its underlying ionic mechanism of 17β-estradiol in cardiac myocytes. Br J Pharmacol 127:429-440.
20. Pogwizd S.M., Bers DM. 2004. Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med 14:61-66.
21. Rhomberg L.R., Goodman JE. 2012. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? Regul Toxicol Pharmacol 64:130-133.
22. Shankar A., Teppala S, Sabanayagam C. 2012. Bisphenol A and peripheral arterial disease: results from the NHANES. Environ Health Perspect 120:1297-1300; doi:10.1289/ ehp.1104114.
23. Shen J.B., Jiang B, Pappano AJ. 2000. Comparison of L-type calcium channel blockade by nifedipine and/or cadmium in guinea pig ventricular myocytes. J Pharmacol Exp Ther 294:562-570.
24. Vandenberg L.N., Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten F.J., Schoenfelder G. 2010. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 118:1055-1070; doi:10.1289/ehp.0901716.
25. Vandenberg L.N., Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee D.H., et al. 2012. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33:378-455.
26. Vandenberg L.N., Hauser R, Marcus M, Olea N, Welshons WV. 2007. Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139-177.
27. Watson C.S., Jeng YJ, Kochukov MY. 2010. Nongenomic signaling pathways of estrogen toxicity. Toxicol Sci 115:1-11.
28. Wetherill Y.B., Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C., et al. 2007. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24:178-198.
29. Yan S., Chen Y, Dong M, Song W, Belcher SM, Wang HS. 2011. Bisphenol A and 17β-estradiol promote arrhythmia in the female heart via alteration of calcium handling. PLoS One 6:e25455; doi:10.1371/journal.pone.0025455.
30. Yan S., Song W, Chen Y, Hong K, Rubinstein J, Wang H-S. 2013. Low-dose bisphenol a and estrogen increase ventricular arrhythmias following ischemia-reperfusion in female rat hearts. Food Chem Toxicol 56C:75-80.